ES2175277T3 - Compuestos de benzofluoreno, intermediarios, compsiciones y procedimientos. - Google Patents

Compuestos de benzofluoreno, intermediarios, compsiciones y procedimientos.

Info

Publication number
ES2175277T3
ES2175277T3 ES97307496T ES97307496T ES2175277T3 ES 2175277 T3 ES2175277 T3 ES 2175277T3 ES 97307496 T ES97307496 T ES 97307496T ES 97307496 T ES97307496 T ES 97307496T ES 2175277 T3 ES2175277 T3 ES 2175277T3
Authority
ES
Spain
Prior art keywords
alkyl
compsitions
intermediaries
procedures
pyrrolidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97307496T
Other languages
English (en)
Inventor
Thomas Alan Crowell
Charles David Jones
Henry Uhlman Bryant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2175277T3 publication Critical patent/ES2175277T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTAN COMPUESTOS DE LA FORMULA I EN LA QUE R SUB,1} ES -H, -OH, -O(ALQUILO C SUB,1} SUB,4}), OCO(ALQUILO C SUB,1} B,1} ,2} 4}), -OCO(ALQUILO C SUB,1} C SUB,6}); R SUB,3} ES 1 TIL INO, DIMETILAMINO, DIETILAMINO, DIISOPROPILAMINO O 1 HEXAMETILENOIMINO; Y N ES 2 O 3; O UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
ES97307496T 1996-09-26 1997-09-25 Compuestos de benzofluoreno, intermediarios, compsiciones y procedimientos. Expired - Lifetime ES2175277T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2675096P 1996-09-26 1996-09-26

Publications (1)

Publication Number Publication Date
ES2175277T3 true ES2175277T3 (es) 2002-11-16

Family

ID=21833583

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97307496T Expired - Lifetime ES2175277T3 (es) 1996-09-26 1997-09-25 Compuestos de benzofluoreno, intermediarios, compsiciones y procedimientos.

Country Status (9)

Country Link
US (1) US5958917A (es)
EP (1) EP0832881B1 (es)
JP (1) JPH10130211A (es)
AT (1) ATE215536T1 (es)
CA (1) CA2214935A1 (es)
DE (1) DE69711527T2 (es)
DK (1) DK0832881T3 (es)
ES (1) ES2175277T3 (es)
PT (1) PT832881E (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2252273T3 (es) * 2000-08-23 2006-05-16 Akzo Nobel N.V. Derivados de 10-aril-11h-benzo(b)fluoreno y analogos destinados para una utilizacion medicinal.
US6686065B2 (en) 2001-12-12 2004-02-03 Canon Kabushiki Kaisha [5]-helicene and dibenzofluorene materials for use in organic light emitting devices
TW200304371A (en) 2002-02-22 2003-10-01 Akzo Nobel Nv Substituted 10-ary1-11H-benzo [b] fluorenes and 7-ary1-5, 6-dihydro-benz [a] anthracenes for selective effects on estrogen receptors
US6849348B2 (en) * 2002-12-31 2005-02-01 Eastman Kodak Company Complex fluorene-containing compounds
TW200530373A (en) * 2003-12-12 2005-09-16 Sumitomo Chemical Co Polymer and light-emitting element using said polymer
EP2006278B2 (en) * 2006-04-13 2016-10-12 Tosoh Corporation Benzofluorene compound and use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138163A (en) * 1965-05-21 1968-12-27 Bristol Myers Co Benzothiophene derivatives having anti-fertility properties
US3394125A (en) * 1965-10-23 1968-07-23 Bristol Myers Co 2-phenyl-3-tertiary-aminoalkoxy phenyl-and corresponding tertiaryaminoalkyl thio benzfurans substituted in the benzo nucleus with an alkoxy or tertiaryamino alkoxy or alkylthio group
US3974186A (en) * 1970-05-14 1976-08-10 Richardson-Merrell Inc. Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
CH564513A5 (en) * 1971-05-24 1975-07-31 Richardson Merrell Inc Basically substd fluoranthene derivs - with antiviral activity
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4230862A (en) * 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
NZ200204A (en) * 1981-04-03 1985-05-31 Lilly Co Eli Benzothiophene derivatives and process for preparation
US4358593A (en) * 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
WO1989002893A1 (en) * 1987-09-30 1989-04-06 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzothiophene derivatives
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US5147880A (en) * 1991-07-22 1992-09-15 Eli Lilly And Company Benzo[a]fluorene compounds
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
GB9220735D0 (en) * 1992-10-02 1992-11-18 British Tech Group Heterocyclic amines
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
GB2303628A (en) * 1995-07-27 1997-02-26 Lilly Co Eli 5-Hydroxy- and 5-phenyl-substituted 1-[4-(aminoalkoxy)phenyl]-2-phenylbenzene derivatives for the treatment of post menopausal symptoms and intermediates
US5811421A (en) * 1995-07-31 1998-09-22 Eli Lilly And Company Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods

Also Published As

Publication number Publication date
ATE215536T1 (de) 2002-04-15
DK0832881T3 (da) 2002-06-17
PT832881E (pt) 2002-08-30
US5958917A (en) 1999-09-28
EP0832881A2 (en) 1998-04-01
DE69711527D1 (de) 2002-05-08
DE69711527T2 (de) 2002-10-31
EP0832881A3 (en) 1998-07-08
CA2214935A1 (en) 1998-03-26
JPH10130211A (ja) 1998-05-19
EP0832881B1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
MX9600743A (es) Compuestos de naftilo, intermediarios y composiciones farmaceuticas a partir de los mismos y proceso para su preparacion.
DK0703228T3 (da) Naphthylforbindelser, mellemprodukter, fremgangsmåder, sammensætninger, som indeholder disse
AR003930A1 (es) Procedimiento para preparar compuestos de 2-fenil-3-fenoxi o feniltio-benzotiofeno y sales farmaceuticamente aceptables, compuestos intermediarios de aplicación exclusiva en dicho procedimiento y metodo para preparar los compuestos intermediarios mencionados
NO940550D0 (no) Alkohol- eller aldehydderivater og deres anvendelse
PL324816A1 (en) Naphtylic and dihydronaphtylic intermediatew compounds, compounds, agents and associated compounds
ES2163716T3 (es) Compuestos de naftaleno y dihidronaftaleno, intermedios, formulaciones y procedimientos.
ES2175277T3 (es) Compuestos de benzofluoreno, intermediarios, compsiciones y procedimientos.
DE69726513D1 (de) Benzo[B]thiophenverbindungen,Zwischenprodukte,Verfahren,Zusammensetzungen und Methode
YU52498A (sh) UPOTREBA 2-ARILBENZO (b) TIOFENA ZA DOBIJANJE LEKA
EA199900238A1 (ru) Нафтильные соединения, промежуточные соединения, препараты и способы применения
DE69612967D1 (en) Optisch aktive thiazolidinonderivate
CA2170479A1 (en) Benzothiophene compounds, intermediates, compositions, and methods
TW349096B (en) Benzothiophene compounds, intermediates, compositions, and methods
RS49886B (sr) Benzotiofenska jedinjenja, intermedijari, kompozicije i metode
ECSP961673A (es) Compuestos de benzotiofeno, productos intermedios, composiciones y procedimientos
CO4940502A1 (es) Compuestos de benzotiofeno, productos intermedios, composiciones y procedimientos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 832881

Country of ref document: ES